Tahl Cindy's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Jan 4, 2022
- Accession no.
- 0001209191-22-000647
- Filed
- Jan 4, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.97M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tahl CindyCIK 0001655472 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | MOption exerciseAcquired | +50,000 | $6.55 | +$327,500 | 219,006 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −4,427 | $57.76F2 | −$255,703.52 | 214,579 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −16,900 | $58.84F3 | −$994,396 | 197,679 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −27,812 | $59.86F4 | −$1,664,826.32 | 169,867 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −861 | $60.31F5 | −$51,926.91 | 169,006 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 66,643 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price of the shares sold ranging from $57.26 to $58.18 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 5.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price of the shares sold ranging from $58.26 to $59.25 per share.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of the shares sold ranging from $59.30 to $60.29 per share.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of the shares sold ranging from $60.30 to $60.33 per share.
Referenced by the price of 1 transaction in Table I.